See also this year's filing and all EDGAR filings for this company.
PDF Report 0001636651_2022_Ovid_Therapeutics_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001636651, Ovid Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 190,479,129 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 242,757 |
| 3 | remainder_Assets | 3,822,871 |
| 4 | LiabilitiesCurrent | 14,798,321 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 37,234,104 |
| 9 | ResearchAndDevelopmentExpense | 46,939,583 |
| 10 | remainder_Expenses | 1,328,818 |
| 11 | remainder_Revenues | 208,382,779 |
| 12 | remainder_NetIncome | -45,690 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 194,544,757 |
| 1 | Liabilities | 14,798,321 |
| 2 | Expenses | 85,502,505 |
| 3 | Revenues | 208,382,779 |
| 4 | StockholdersEquity | 179,746,436 |
| 5 | NetIncome | 122,834,584 |
| 6 | ComprehensiveNetIncome | 122,834,584 |
| 7 | BaseVar | 251,637,026 |
| 8 | EconomicCapitalRatio | 4.13 |
Edgar->Model Mapping
Feature Distribution
Change over Time
